epiTCR: a highly sensitive predictor for TCR–peptide binding
Bioinformatics · 04.05.2023 · 39 (5)
DOI: 10.1093/bioinformatics/btad284 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bioinformatics, online erschienen am 24.04.2023. Verfasst von My-Diem Nguyen Pham und 9 weiteren Autor:innen. Beteiligte Einrichtung: Medical Genetics Institute, Ho Chi Minh City, Vietnam. Hauptthemen laut MEDLINE: Peptides, Antigens. Die Arbeit wurde bisher 74-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NexCalibur Therapeutics.
Abstract (Originalsprache)
Motivation Predicting the binding between T-cell receptor (TCR) and peptide presented by human leucocyte antigen molecule is a highly challenging task and a key bottleneck in the development of immunotherapy. Existing prediction tools, despite exhibiting good performance on the datasets they were built with, suffer from low true positive rates when used to predict epitopes capable of eliciting T-cell responses in patients. Therefore, an improved tool for TCR–peptide prediction built upon a large dataset combining existing publicly available data is still needed. Results We collected data from five public databases (IEDB, TBAdb, VDJdb, McPAS-TCR, and 10X) to form a dataset of >3 million TCR–peptide pairs, 3.27% of which were binding interactions. We proposed epiTCR, a Random Forest-based method dedicated to predicting the TCR–peptide interactions. epiTCR used simple input of TCR CDR3β sequences and antigen sequences, which are encoded by flattened BLOSUM62. epiTCR performed with area under the curve (0.98) and higher sensitivity (0.94) than other existing tools (NetTCR, Imrex, ATM-TCR, and pMTnet), while maintaining comparable prediction specificity (0.9). We identified seven epitopes that contributed to 98.67% of false positives predicted by epiTCR and exerted similar effects on other tools. We also demonstrated a considerable influence of peptide sequences on prediction, highlighting the need for more diverse peptides in a more balanced dataset. In conclusion, epiTCR is among the most well-performing tools, thanks to the use of combined data from public sources and its use will contribute to the quest in identifying neoantigens for precision cancer immunotherapy. Availability and implementation epiTCR is available on GitHub (https://github.com/ddiem-ri-4D/epiTCR).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Medical Genetics Institute, Ho Chi Minh City, Vietnam.
- NexCalibur Therapeutics, Wilmington, DE, United States.
- University of Medicine & Pharmacy, Ho Chi Minh City, Vietnam.
ORCID-Profile: My-Diem Nguyen Pham, Thien-Phuc Hoang Nguyen, Vy Nguyen
Förderung
- NexCalibur Therapeutics
Zitieren
APA
Pham, M. N., Nguyen, T. N., Tran, L. S., Nguyen, Q. B., Nguyen, T. H., Pham, T. M. Q., Nguyen, H. N., Giang, H., Phan, M. D., & Nguyen, V. (2023). epiTCR: a highly sensitive predictor for TCR–peptide binding. Bioinformatics, 39(5). https://doi.org/10.1093/bioinformatics/btad284
Vancouver
Pham MN, Nguyen TN, Tran LS, Nguyen QB, Nguyen TH, Pham TMQ, et al. epiTCR: a highly sensitive predictor for TCR–peptide binding. Bioinformatics. 2023;39(5). doi:10.1093/bioinformatics/btad284
BibTeX
@article{Pham2023,
author = {Pham, My-Diem Nguyen and Nguyen, Thanh-Nhan and Tran, Le Son and Nguyen, Que-Tran Bui and Nguyen, Thien-Phuc Hoang and Pham, Thi Mong Quynh and Nguyen, Hoai-Nghia and Giang, Hoa and Phan, Minh-Duy and Nguyen, Vy},
title = {epiTCR: a highly sensitive predictor for TCR–peptide binding},
journal = {Bioinformatics},
year = {2023},
volume = {39},
number = {5},
doi = {10.1093/bioinformatics/btad284}
}
EUVIMED